HAE FY 2009 Earnings Report — Haemonetics Corporation Revenue & Financial Results | Market Cap Arena

Haemonetics CorporationHAE

FY 2009 Earnings

Reported May 22, 2009

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2009	Prior Q	FY 2008	QoQ Change	YoY Change
Revenue	$598M	—	$516M	—	15.8%
Op. Income	$86M	—	$70M	—	21.7%
Gross Margin	51.5%	—	49.9%	—	1.6pp
Net Margin	9.9%	—	10.1%	—	-0.1pp
EPS (Diluted)	$1.14	—	$0.97	—	17.5%
Free Cash Flow	$60M	—	$20M	—	201.8%

Revenue Flow

Item	Amount
REVENUE	$598M
Cost of Revenue	$290M
GROSS PROFIT	$308M
R&D Expenses	$24M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$199M
Other Expenses	$0
Operating Expenses	$223M
Cost & Expenses	$512M
OPERATING INCOME	$86M
Interest Income	$2M
Interest Expense	$64.0K
Other Income/Expenses	-$565.0K
INCOME BEFORE TAX	$85M
Income Tax Expense	$26M
Net Income from Continuing Ops	$59M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$59M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$59M
D&A	$36M
EBIT	$85M
EBITDA	$122M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$598M
Cost of Revenue	$290M
GROSS PROFIT	$308M
R&D Expenses	$24M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$199M
Other Expenses	$0
Operating Expenses	$223M
Cost & Expenses	$512M
OPERATING INCOME	$86M
Interest Income	$2M
Interest Expense	$64.0K
Other Income/Expenses	-$565.0K
INCOME BEFORE TAX	$85M
Income Tax Expense	$26M
Net Income from Continuing Ops	$59M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$59M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$59M
D&A	$36M
EBIT	$85M
EBITDA	$122M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$59M
Depreciation & Amortization	$36M
Stock-Based Compensation	$10M
Deferred Income Tax	$2M
Other Non-Cash Items	$4M
Change in Working Capital	$5M
OPERATING CASH FLOW	$116M
Capital Expenditure	-$56M
Acquisitions (Net)	-$6M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$2M
NET CASH FROM INVESTING	-$60M
Net Debt Issuance	-$6M
Common Stock Repurchased	-$60M
Common Dividends Paid	$0
Other Financing Activities	$7M
NET CASH FROM FINANCING	-$31M
FREE CASH FLOW	$60M
Net Change in Cash	$23M

Balance Sheet

Item	Amount
Cash & Equivalents	$157M
Short-Term Investments	$0
Net Receivables	$114M
Inventory	$77M
Other Current Assets	$36M
TOTAL CURRENT ASSETS	$382M
PP&E (Net)	$138M
Goodwill	$56M
Intangible Assets	$65M
Long-Term Investments	$0
Tax Assets	$3M
Other Non-Current Assets	$5M
TOTAL NON-CURRENT ASSETS	$267M
TOTAL ASSETS	$650M
Account Payables	$21M
Short-Term Debt	$695.0K
Deferred Revenue	$0
Other Current Liabilities	$17.0K
TOTAL CURRENT LIABILITIES	$93M
Long-Term Debt	$5M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$3M
Other Non-Current Liabilities	$8M
TOTAL NON-CURRENT LIABILITIES	$17M
TOTAL LIABILITIES	$110M
Common Stock	$256.0K
Additional Paid-In Capital	$227M
Retained Earnings	$310M
Treasury Stock	$0
Accum. Other Comp. Income	$3M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$540M
Minority Interest	$0
TOTAL EQUITY	$540M
TOTAL LIABILITIES & EQUITY	$650M
Total Debt	$6M
Net Debt	-$151M